ASPEN PHAR.UN.ADR /1 O.N. (LDZU) — Tangible Net Worth Ratio
ASPEN PHAR.UN.ADR /1 O.N. (LDZU) has a Tangible Net Worth Ratio of 43.1% as of December 2025. This metric is calculated by deducting intangible assets (€46.13 Billion) from net assets (€81.09 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore ASPEN PHAR.UN.ADR /1 O.N. annual equity growth to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
ASPEN PHAR.UN.ADR /1 O.N. Tangible Net Worth Ratio (2022–2025)
This chart shows how ASPEN PHAR.UN.ADR /1 O.N.'s Tangible Net Worth Ratio has changed across 4 annual periods from 2022 to 2025. As of December 2025, the ratio stands at 43.1%, reflecting net assets of €81.09 Billion with intangible assets of €46.13 Billion EUR. For live market cap and overall valuation, see market cap of ASPEN PHAR.UN.ADR /1 O.N..
Annual Tangible Net Worth Ratio for ASPEN PHAR.UN.ADR /1 O.N. (2022–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for ASPEN PHAR.UN.ADR /1 O.N. from 2022 to 2025, covering 4 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. Explore ASPEN PHAR.UN.ADR /1 O.N. (LDZU) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.
| Year | Tangible NW Ratio | Net Assets (EUR) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 20.8% | €84.89 Billion | €67.21 Billion | €135.89 Billion | ▼ -1.4 pp |
| 2024 | 22.2% | €84.86 Billion | €66.03 Billion | €139.06 Billion | ▼ -4.6 pp |
| 2023 | 26.8% | €86.24 Billion | €63.10 Billion | €134.28 Billion | ▲ +2.5 pp |
| 2022 | 24.4% | €70.94 Billion | €53.65 Billion | €111.38 Billion | — |